UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response definition criteria for ELISPOT assays revisited

Cancer Immunology, Immunotherapy, 2010-10, Vol.59 (10), p.1489-1501

2010

Volltextzugriff (PDF)

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Vaccine, 2013-04, Vol.31 (16), p.2089-2096

2013

Volltextzugriff (PDF)

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

The New England journal of medicine, 2018-07, Vol.379 (4), p.327-340

2018

Volltextzugriff (PDF)

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

The Lancet (British edition), 2008-11, Vol.372 (9653), p.1894-1905

2008

Volltextzugriff (PDF)

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P209-P209, Article P209

2009

Volltextzugriff (PDF)

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P190-P190, Article P190

2009

Volltextzugriff (PDF)

P16-42. Characterisation of HIV-1 specific T-cell responses in exposed uninfected individuals from a London cohort

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P271-P271, Article P271

2009

Volltextzugriff (PDF)

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Retrovirology, 2012-09, Vol.9 (S2), p.O55-O55, Article O55

2012

Volltextzugriff (PDF)

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1638-1649

2006

Volltextzugriff (PDF)

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease

PloS one, 2018-12, Vol.13 (12), p.e0207878-e0207878

2018

Volltextzugriff (PDF)

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

Journal of immunological methods, 2007-05, Vol.323 (1), p.39-54

2007

Volltextzugriff (PDF)

Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Journal of Virology, 2003-01, Vol.77 (1), p.799-803

2003

Volltextzugriff (PDF)

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine

The Journal of infectious diseases, 2006-12, Vol.194 (12), p.1650-1660

2006

Volltextzugriff (PDF)

Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants but enhanced response rates and magnitude when ALVAC-HIV and gp120 were co-administered

Journal of the International AIDS Society, 2021-01, Vol.24 (S1), p.44

2021

Volltextzugriff (PDF)

Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants

Journal of the International AIDS Society, 2021-01, Vol.24 (S1), p.44

2021

Volltextzugriff (PDF)

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

Journal of Virology, 2003-12, Vol.77 (23), p.12764-12772

2003

Volltextzugriff (PDF)

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

Journal of immunological methods, 2006-08, Vol.315 (1), p.121-132

2006

Volltextzugriff (PDF)

Dynamique des réponses immunitaires à un vaccin préventif contre le VIH-1 : modélisation à partir d’un essai clinique vaccinal

Revue d'épidémiologie et de santé publique, 2015-05, Vol.63, p.S38-S38

2015

Volltextzugriff (PDF)

Hazard-based nonparametric survivor function estimation

Journal of the Royal Statistical Society. Series B, Statistical methodology, 2004-01, Vol.66 (2), p.305-319

2004

Volltextzugriff (PDF)

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop

Journal of acquired immune deficiency syndromes (1999), 2007-01, Vol.44 (1), p.49-60

2007

Volltextzugriff (PDF)

Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa

The Lancet infectious diseases, 2011-05, Vol.11 (7), p.507-515

2011

Volltextzugriff (PDF)

VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP)

Journal of allergy and clinical immunology, 2005-04, Vol.115 (4), p.892-892

2005

Volltextzugriff (PDF)

Statistical evaluation of HIV vaccines in early clinical trials

Contemporary clinical trials, 2006-04, Vol.27 (2), p.147-160

2006

Volltextzugriff (PDF)

An adjustment to improve the bivariate survivor function repaired NPMLE

Lifetime data analysis, 2005-09, Vol.11 (3), p.291-307

2005

Volltextzugriff (PDF)

Analysis of task-based functional MRI data preprocessed with fMRIPrep

Nature protocols, 2020-07, Vol.15 (7), p.2186-2202

2020

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(71)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(37)
Humans
(26)
Female
(18)
Male
(18)
Biological And Medical Sciences
(15)
Animals
(11)
Aids Vaccines - Immunology
(10)
Adult
(9)
Hiv
(9)
Hiv-1 - Immunology
(9)
Human Immunodeficiency Virus
(9)
Immunology
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Human Immunodeficiency Virus 1
(8)
Medical Research
(8)
Medical Sciences
(8)
Microbiology
(8)
Physical Sciences
(8)
Vaccines
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Response definition criteria for ELISPOT assays revisited

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

P16-42. Characterisation of HIV-1 specific T-cell responses in exposed uninfected individuals from a London cohort

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine

Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants but enhanced response rates and magnitude when ALVAC-HIV and gp120 were co-administered

Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

Dynamique des réponses immunitaires à un vaccin préventif contre le VIH-1 : modélisation à partir d’un essai clinique vaccinal

Hazard-based nonparametric survivor function estimation

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop

Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa

VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP)

Statistical evaluation of HIV vaccines in early clinical trials

An adjustment to improve the bivariate survivor function repaired NPMLE

Analysis of task-based functional MRI data preprocessed with fMRIPrep

Suchergebnisse filtern